Recognized for its prowess in the M&A space, Goodwin advises clients from the pharmaceutical, AI, fintech, and real estate industries on tender offers, divestitures and take-privates, and spin offs, in addition to acting on both the private and public side for mature clients. With experience in the regulatory, transactional, and antitrust elements of M&A, the group is collectively led by Boston-based Michael Kendall, who concentrates on corporate finance, private equity, and venture capital deals. Silicon Valley- based co-head Lawrence Chu is well-verse in handling global M&A for tech companies, while co-head Joshua Zachariah covers corporate governance and strategic M&A representations from the firm’s New York office. Also in Boston is Stuart Cable, who has ample experience in representing boards of directors in life sciences-focused M&A.
Legal 500 Editorial commentary
- Profile
Key clients
- Ansys
- Cvent Holding Corp
- Deciphera Pharmaceuticals
- EQRx
- Fusion Pharmaceuticals
- Novo Holdings
- Qatalyst Partners
- Qualtrics International Inc.
- Retina Consultants of America
- Thoma Bravo
Lawyers
Practice head
Michael Kendall; Lawrence Chu; Joshua Zachariah
Other key lawyers
Stuart Cable